Robertson JFR, Coleman RE, Cheung KL, Evans A, et al. Correction: Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT). Clin Cancer Res 2022;28:5469.
PMID: 36519303